OrbiMed

Growth Equity
New York, New York, United States
Website

Founded in 1989, OrbiMed is a growth equity firm based in New York. The firm seeks to invest in companies operating in the biopharmaceutical, life sciences, digital health, healthcare services, medical devices, and diagnostic sectors based in Asia, Europe, and North America. This firm is a Registered Investment Adviser (RIA).

48companies
0lead
0follow-on
Portfolio Companies
48 companies

Candid Therapeutics

Drug Discovery

Iambic

BlossomHill Therapeutics

Aspen Neuroscience

Triveni Bio

Drug Discovery

Pathalys Pharma

+42 more companies

Sign in to see the full portfolio

Sign In